DJIA 16,014.38 -12.67 -0.08%
NASDAQ 4,268.76 -14.99 -0.35%
S&P 500 1,852.21 -1.23 -0.07%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

49.16 0.33 (0.68%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MRK $49.16 0.68%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $48.69
Previous Close $48.83
Daily Range $48.40 - $49.57
52-Week Range $45.69 - $61.70
Market Cap $137.3B
P/E Ratio 13.60
Dividend (Yield) $1.84 (3.8%)
Ex-Dividend Date
Dividend Pay Date
12/11/15
01/08/16
Volume 10,648,564
Average Daily Volume 12,665,261
Current FY EPS $3.57

Sector

Healthcare

Industry

Drug Makers

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website: http://www.merck.com/

News & Commentary

Pfizer Gets Back to Growth

Guidance for 2016 suggests that a corner is turning for this industry Goliath.

Curing Hepatitis C: How Gilead Sciences Plans to Beat Merck

Merck's Zepatier poses a new challenge to Gilead's best-selling drug, but maybe it's not as threatening as some think.

1 Chart That's Bringing Big Smiles to America's Largest Companies

You might be witnessing a sea of red, but the recent retracement in this index could be a very good thing for America's largest companies.

Bristol-Myers' Daklinza-Sovaldi Label Expanded by the FDA

TapImmune Tackles Ovarian Cancer In Fast Track Phase II Clinical Trials

One Put, One Call Option To Know About for Merck & Co.

How To Invest In An Aging World With The 'Live Long & Prosper' ETF

4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now

Give Merck Some Credit For Zepatier

How Analysts View Pfizer and Merck After Earnings

See More MRK News...

MRK's Top Competitors

MRK $49.16 (0.68%)
Current stock: MRK
JNJ $101.97 (-0.03%)
Current stock: JNJ
NVS $72.62 (-0.77%)
Current stock: NVS
RHHBY $31.14 (-0.35%)
Current stock: RHHBY